China's strategic investments in higher education, particularly through Project 985, have propelled its universities to ...

Bharat Biotech’s oral cholera vaccine, Hillchol, aims to ease a critical global shortfall, with the world currently lacking ...

Biowave will address this lackluster entrepreneurial activity and bring more VC investment into India’s life sciences.

High-impact workshop on ‘Biotechnology Applications for Crop Improvement’ highlights genetically modified and gene-edited ...

India is set to undertake its first-ever biological experiments aboard the International Space Station (ISS). Announcing this ...

Bharat Biotech's Hillchol oral cholera vaccine completes phase III trials, proving non-inferiority and potential for global distribution.